Hg sells Kinapse to Syneos

Under Hg's tenure, the business built out its senior management team and increased its overall headcount from 440 to around 600. According to a recent statement, the business experienced double-digit growth in its most recent financial year.

The GP was invested in the business via HgCapital 7 Fund and alongside its feeder fund, HgCapital Trust.

Previous funding
Kinapse first received private equity backing in 2012, when Synova Capital invested in the company. Synova then sold its stake to Hg four years later in a deal that generated a 16.1x return and an IRR of 126% for the vendor.

Company
Founded by two former Accenture partners in 2005, London-headquartered Kinapse provides consultancy services to the life sciences industry, with a focus on regulatory compliance and quality. The company has additional operations in India and the US.

People
Kinapse - Dawn Marriott-Sims (executive chairperson).
Syneos Health - Alistair Macdonald (CEO).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Exits
• UK / Ireland
• Support services
• United Kingdom
• HgCapital
• Trade sale